Skip to main content
. 2024 Mar 18;50(2):178–191. doi: 10.1590/S1677-5538.IBJU.2023.0477

Supplementary Table 1. Patient characteristics and association with 30-days and 90-days readmission rate.

Characteristics 30-days readmission 90-days readmission
OR (95% CI) P OR (95% CI) P
Gender (Male vs. Female 1) 0.993 (0.469-2.099) 0.986 0.952 (0.475-1.909) 0.891
Age (<70vs. ≥70 1) 0.663 (0.326-1.347) 0.256 0.490 (0.250-0.960) 0.037
BMI
30-40 vs. <301 1.643 (0.804-3.361) 0.173 1.713 (0.879-3.337) 0.113
≥40 vs. <301 1.800 (0.551-5.871) 0.329 1.692 (0.547-5.229) 0.361
Method of Diversion (ICUD vs. ECUD 1) 1.272 (0.383-4.228) 0.693 0.726 (0.323-1.632) 0.439
Diversion type
Indiana Pouch vs. Ileal conduit1 1.355 (0.503-3.654) 0.548 1.822 (0.727-4.565) 0.200
Neobladder vs. Ileal conduit1 1.475 (0.664-3.277) 0.339 1.735 (0.818-3.677) 0.150
Others vs. Ileal conduit1 2.194 (0.346-13.909) 0.404 3.827 (0.607-24.101) 0.152
Preoperative diagnosis (Others vs. Bladder cancer 1) 1.313 (0.571-3.022) 0.521 1.471 (0.675-3.206) 0.331
Smoking status
Former smoker vs. Never smoker1 1.968 (0.760-5.093) 0.162 1.534 (0.664-3.540) 0.316
Current smoker vs. Never smoker1 1.545 (0.563-4.237) 0.398 1.104 (0.451-2.703) 0.827
Diabetes Mellitus (Yes vs. No1) 1.581 (0.781-3.199) 0.202 1.477 (0.760-2.871) 0.249
Neoadjuvant Chemotherapy (Yes vs. No1) 0.990 (0.483-2.032) 0.979 0.855 (0.435-1.681) 0.650
Intravesical treatment (Yes vs. No1) 0.826 (0.344-1.982) 0.668 0.773 (0.342-1.748) 0.537
Pelvic Radiation therapy (Yes vs. No1) 1.450 (0.510-4.118) 0.485 1.647 (0.613-4.424) 0.322
ECOG (0 vs. ≥11) 0.608 (0.287-1.287) 0.194 0.550 (0.274-1.103) 0.092
ASA (≥4 vs. ≤31) 1.862 (0.717-4.835) 0.201 1.929 (0.768-4.847) 0.162
ACCI (≥7 vs. ≤61) 1.580 (0.754-3.312) 0.225 1.431 (0.709-2.888) 0.317

ECUD = extracorporeal urinary diversion; ICUD = intracorporeal urinary diversion; SD = standard deviation

1

calculated as a reference